NexPoint Announces Co-investment in NexPoint Life Sciences II DST, Continuing Commitment to Life Sciences with a Focus on CDMOs and cGMP Facilities
DALLAS, Sept. 12, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment platform, announces it has made an initial investment in NexPoint Life Sciences II DST, a Delaware statutory trust (DST), through a fund advised by its affiliate. The investment represents 6% of the total equity available. NexPoint plans to increase the investment size, ultimately targeting 10%-12% of the total equity […]
NexPoint Capital, Inc. Announces Tender Offer for Common Stock
DALLAS, Aug. 23, 2023 /PRNewswire/ — NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company sponsored and managed by NexPoint Advisors, L.P., today announced that it will commence a voluntary tender offer on or about August 23, 2023 (the “Tender Offer”) for up to 2.5% of its outstanding common stock (“Shares”). The purchase price of each […]
NexPoint Capital, Inc. Announces Tender Offer for Common Stock
DALLAS, Aug. 23, 2023 /PRNewswire/ — NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company sponsored and managed by NexPoint Advisors, L.P., today announced that it will commence a voluntary tender offer on or about August 23, 2023 (the “Tender Offer”) for up to 2.5% of its outstanding common stock (“Shares”). The purchase price of each […]
Dallas’ Cityplace office tower is next up for apartments
Read more from the Dallas Morning News. Read More
NexPoint Capital, Inc. Announces Tender Offer for Common Stock
DALLAS, June 26, 2023 /PRNewswire/ — NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company sponsored and managed by NexPoint Advisors, L.P., today announced the expiration and final results for its tender offer (the “Tender Offer”) for up to 2.5% of its outstanding common stock (“Shares”) at a price of $5.26 per Share (an amount approved […]
NexPoint Capital, Inc. Announces Tender Offer for Common Stock
DALLAS, May 19, 2023 /PRNewswire/ — NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company sponsored and managed by NexPoint Advisors, L.P., today announced that it will commence a voluntary tender offer on or about May 19, 2023 (the “Tender Offer”) for up to 2.5% of its outstanding common stock (“Shares”). The purchase price of each […]
NexPoint Capital, Inc. Announces Tender Offer for Common Stock
DALLAS, May 19, 2023 /PRNewswire/ — NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company sponsored and managed by NexPoint Advisors, L.P., today announced that it will commence a voluntary tender offer on or about May 19, 2023 (the “Tender Offer”) for up to 2.5% of its outstanding common stock (“Shares”). The purchase price of each […]
NexPoint’s Life Sciences Project in Plano, Texas Renamed Texas Research Quarter
DALLAS, May 18, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment firm, today announced that its cutting-edge life sciences real estate project known as the “TxS District,” a proposed 200-acre development in Plano, Texas, has been renamed the “Texas Research Quarter.” Originally signifying “Technology x Science,” the new Texas Research Quarter (“TRQ”) name was chosen to better reflect […]
NexPoint Expands Life Sciences Real Estate Footprint with Acquisition of Two Properties from Adare Pharma Solutions
Properties were indirectly acquired by NexPoint Life Sciences II DST, a Delaware statutory trust seeking to raise $42 million in equity from accredited investors via a private placement offering DALLAS, May 17, 2023 /PRNewswire/ — NexPoint, a multibillion-dollar alternative investment platform, today announced the acquisition of two life sciences industrial properties located in Philadelphia, Pennsylvania, from Frontida Biopharm, LLC, a company in the […]
Featured Video: Focus on Alternatives: Real Estate Investing in Life Sciences
In an interview with ADISA board member Greg Mausz, Nexpoint’s chief financial officer and executive vice president of finance, Brian Mitts, provides insight on how life sciences investing functions in real estate. “So, it’s in pharmaceuticals and biotech, but it’s not the companies themselves, it’s in the real estate that they utilize,” said Mitts. Mitts […]
